The primary objective is to determine whether continuous sensing, control and mitigation of home indoor air quality influences the frequency of asthma related symptoms, as measured by Serum IgE, Spirometry with exhaled Nitric Oxide, missed school and workdays, need for pharmacologic intervention (albuterol, oral steroids), frequency of sick visits to pulmonologist or primary care provider (PCP), urgent care / emergency department visits, and hospitalizations
Participants will be in the research study for approximately 2 years. There will be 11 visits to the clinic for monitoring of asthma symptoms and pulmonary function and 16 interval contacts with research staff made by either telephone or email to monitor asthma symptoms. There will also be 5 visits to participants' homes by technicians from Emerson Climate Technologies and/or an electrician in cooperation with Emerson. During these visits Emerson employees will assess participants' homes to determine if they qualify for the study and install study equipment to monitor air quality for the first half of the study and monitor and mitigate air quality for the second half of the study. At the end of the study, the technicians and/or electrician from Emerson will reset the study equipment or replace participants' original equipment, if that is their wish. Participants will be enrolled in the research study for approximately 2 years. The first year, technicians from the study sponsor will install indoor air quality monitoring equipment in the participants' homes and information about the air quality in their home as well as baseline health and asthma information will be collected. This will be done through continuous sensing via an Atmocube air quality sensor, and a portable air quality sensor, the Atmotube. Beginning in the second half of the study, mitigation strategies of a smart home thermostat, the Sensi Touch Smart Thermostat, a smart bath fan control, the Enbrighten Z-wave Switch, and high quality furnace filter, 3M Filtrete MPR 2800 Ultrafine Particle Reduction Air Filter, will be employed. Information about the participants' asthma, health status, and air quality in the homes will continue to be collected.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
10
Mitigation of indoor air quality with use of smart thermostat, smart bath fan control, and high quality furnace filters
Dayton Childrens Hospital
Dayton, Ohio, United States
Asthma Control Test questionnaire
Monthly Asthma Control Test by History. Possible scores ranging from 0 (worst control)-27 (best control) for patients ages 6-11 or 0 (worst control)- 25 (best control) for patients ages 12-16.
Time frame: Through study completion, approximately 2 years
Number of asthma related visits to Primary Care Physician, Emergency Department or Urgent Care
Sick Visits due to asthma
Time frame: Through study completion, approximately 2 years
Number of missed school and work days
Number of missed school and work days due to asthma symptoms
Time frame: Through study completion, approximately 2 years
Frequency of asthma Medication Use
Use of asthma rescue inhaler and systemic steroids
Time frame: Through study completion, approximately 2 years
Spirometry with exhaled nitric oxide
measurement of Forced Expiratory Volume in 1 second measured quarterly
Time frame: Weeks 1, 13, 25, 37, 49, 53, 65, 77, 89, 101, 105
Physical examination
head, eyes, ears, nose, throat (HEENT), lungs, cardiovascular, abdominal, neurologic, and musculoskeletal exam by a licensed physician.
Time frame: Weeks 1, 13, 25, 37, 49, 53, 65, 77, 89, 101, 105
Mini Paediatric Asthma Quality of Life Questionnaire (MiniPAQLQ)
Questionnaire assessing quality of life for patients with asthma. Possible scores range from 13 (worst quality of life)- 91 (best quality of life)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: Weeks 1, 49, 53, 105
Concentration in serum of immunoglobulin E (IgE)
blood test measuring IgE
Time frame: Weeks 1, 53, 105
height
standing height in centimeters without shoes
Time frame: Weeks 1, 13, 25, 37, 49, 53, 65, 77, 89, 101, 105
weight
weight in kilograms without shoes
Time frame: Weeks 1, 13, 25, 37, 49, 53, 65, 77, 89, 101, 105
heart rate
heart beats per minute
Time frame: Weeks 1, 13, 25, 37, 49, 53, 65, 77, 89, 101, 105
respiratory rate
number of breaths per one minute
Time frame: Weeks 1, 13, 25, 37, 49, 53, 65, 77, 89, 101, 105
blood pressure
systolic over diastolic blood pressure measured in mm/Hg
Time frame: Weeks 1, 13, 25, 37, 49, 53, 65, 77, 89, 101, 105
oxygen saturation
percent of hemoglobin saturated by oxygen in blood
Time frame: Weeks 1, 13, 25, 37, 49, 53, 65, 77, 89, 101, 105